Satisfactory developer Coffee Stain Studios is back at work after its holiday break, and it's already deployed a long-awaited patch for the factory building game that upgrades it to the Steam Deck ...
I prefer to play my games without mods or console commands to get as close to the intended experience as possible. But sometimes something breaks and you need to reset your character, you have an ...
Unfortunately, folks who were hoping to pick up the game on their console of choice and dig into Satisfactory with friends on PC won’t be able to do so. Here’s a breakdown of Satisfactory’s crossplay ...
CAMBRIDGE, England--(BUSINESS WIRE)--Ignota Labs, the AI drug turnaround company, has announced its acquisition of Kronos’s clinical assets, istisociclib, a CDK9 inhibitor, and entospletinib and ...
Noble Audio has launched its new flagship in-ear monitor, the Kronos, now in full production after first appearing as a limited-edition 10th anniversary model. It is based on the Chronicle design but ...
The new Kronos IEMs from have nine drivers and a six-way crossover but an impedance of less than 35Ω. Noble Audio has announced the launch of its latest pair of flagship in-ear monitors. The Kronos ...
Kronos is a HOLD: TiO2 demand should rise, but KRO lacks operating leverage and control over key feedstocks to benefit from upside. KRO faces significant competition from Chinese producers, especially ...
Kronos Quartet are marking the 80th anniversary of the first nuclear detonation by covering Bob Dylan‘s “A Hard Rain’s A-Gonna Fall” with the Hard Rain Collective. Proceeds benefit the Red Hot ...
Yesterday, July 16, marked the 80th anniversary of the Trinity Test, the US military’s first detonation of a nuclear weapon in the deserts of New Mexico. To observe the event and its devastating ...
With the walls quickly closing in, Kronos Bio has accepted a buyout from notorious biotech acquirer Concentra Biosciences. Tang Capital Partners’ Concentra inked a definitive deal to acquire Kronos’ ...
(RTTNews) - Kronos Bio (KRON) has entered into a definitive merger agreement with Concentra Biosciences, LLC, whereby Concentra will acquire Kronos Bio for $0.57 in cash per share of Kronos Bio common ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The biotech downturn claims ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results